Akme Fintrade Board Approves ₹85.75 Crore Preferential Warrant Issue, Schedules EGM

2 min read     Updated on 21 Feb 2026, 02:37 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Akme Fintrade (India) Limited has approved a significant preferential warrant issue worth ₹85.75 crore involving 12.25 crore warrants at ₹7 each, distributed among 15 allottees including promoters and non-promoters. The warrants are convertible into equity shares within 18 months, requiring 25% payment upfront and 75% at conversion, with an EGM scheduled for March 20, 2026 to seek shareholder approval.

33210462

*this image is generated using AI for illustrative purposes only.

Akme Fintrade (India) Limited has announced significant corporate developments following its board meeting held on February 21, 2026. The company's board of directors approved a substantial preferential warrant issue and scheduled an extraordinary general meeting to seek shareholder consent for the proposal.

Board Meeting Outcomes

The board meeting, which commenced at 11:00 AM and concluded at 2:15 PM on February 21, 2026, resulted in several key approvals. The primary decision involved the preferential issue of warrants, along with scheduling an EGM and appointing a scrutinizer for the meeting.

Decision: Details
Warrant Issue Approval: Up to 12.25 crore warrants
Total Value: ₹85.75 crore
Warrant Price: ₹7 per warrant
Conversion Period: 18 months from allotment
EGM Date: March 20, 2026
Scrutinizer: M/s. Ronak Jhuthawat & Co.

Warrant Issue Structure

The approved warrant issue involves up to 12,25,00,000 warrants, each convertible into one equity share of ₹1 face value. The warrants are priced at ₹7 each, representing the floor price as per SEBI ICDR Regulations. The total issue size aggregates to ₹85,75,00,000, subject to member approval and regulatory clearances.

The conversion mechanism requires warrant holders to pay 25% of the consideration at application and the remaining 75% at conversion. Each warrant can be converted into one equity share within 18 months of allotment. Failure to exercise warrants within this period will result in lapse and forfeiture of the 25% consideration paid.

Proposed Allottee Categories

The warrant allocation spans 15 proposed allottees across promoter and non-promoter categories. The distribution includes significant allocations to both individual investors and corporate entities.

Category: Key Allocations
Promoter Category:
Nirmal Kumar Jain: 1,00,00,000 warrants
Akme Build Estate Limited: 1,50,00,000 warrants
Non-Promoter Category:
Infront Enterprises Private Limited: 2,50,00,000 warrants
Akme Finnova Advisors LLP: 1,50,00,000 warrants
Finmen Advisors and Consultants Pvt Ltd: 1,00,00,000 warrants
Anish Dhing HUF: 1,00,00,000 warrants
Stellant Securities (India) Limited: 1,00,00,000 warrants

Post-Conversion Shareholding Impact

The warrant conversion will significantly alter the company's shareholding pattern. Assuming full conversion of all warrants, Nirmal Kumar Jain's shareholding will adjust from 26.74% to 22.62%, while new stakeholders will gain meaningful positions in the company.

Stakeholder: Pre-Issue % Post-Conversion %
Nirmal Kumar Jain: 26.74% 22.62%
Infront Enterprises Pvt Ltd: 0.17% 4.44%
Akme Build Estate Limited: 0.00% 2.58%
Akme Finnova Advisors LLP: 0.00% 2.58%
Stellant Securities (India) Limited: 0.47% 2.09%

Regulatory Compliance and Next Steps

The warrant issue requires compliance with multiple regulatory frameworks, including the Companies Act 2013, SEBI ICDR Regulations, and listing regulations. The company has scheduled the extraordinary general meeting for March 20, 2026, through video conferencing to seek member approval.

M/s. Ronak Jhuthawat & Co., Practicing Company Secretaries, have been appointed as scrutinizers for the EGM. The meeting will be conducted through video conferencing and other audio-visual means, ensuring broader shareholder participation in the approval process. The disclosure has been made pursuant to Regulation 30 of SEBI Listing Regulations and uploaded on the company's website at www.akmefintrade.com .

Historical Stock Returns for Akme Fintrade

1 Day5 Days1 Month6 Months1 Year5 Years
+8.29%+18.31%+4.44%-15.15%-15.15%-95.59%

Akme Fintrade Receives CARE BBB+ Rating for ₹465 Crore Facilities

2 min read     Updated on 05 Feb 2026, 03:43 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

CARE Ratings assigned CARE BBB+ stable rating to Akme Fintrade's ₹250 crore term loan and ₹200 crore NCDs while reaffirming A3+ for ₹15 crore commercial paper. The rating reflects adequate capitalisation from ₹132 crore IPO proceeds, healthy profitability with 5.70% RoTA in FY25, and improving asset quality. However, operations remain geographically concentrated with 63% AUM in Rajasthan and modest ₹767 crore scale as of September 2025.

31831998

*this image is generated using AI for illustrative purposes only.

Akme fintrade (india) Limited has received credit rating assignments from CARE Ratings Limited for its various financial instruments totaling ₹465 crore. The Udaipur-based non-banking financial company informed stock exchanges on February 05, 2026, about the rating actions under SEBI listing regulations.

Rating Details and Assignments

CARE Ratings assigned long-term ratings of CARE BBB+ with stable outlook to the company's major facilities while reaffirming its short-term rating. The rating agency evaluated the standalone credit profile of the NBFC in arriving at these ratings.

Instrument/Facility Amount (₹ crore) Rating Assigned Rating Action
Long Term Bank Facilities 250.00 CARE BBB+; Stable Assigned
Non-Convertible Debentures 200.00 CARE BBB+; Stable Assigned
Commercial Paper 15.00 CARE A3+ Reaffirmed

Key Rating Strengths

The rating factors in several positive aspects of Akme Fintrade's financial profile. The company's capitalisation position remains adequate, supported by healthy equity infusion of ₹132 crore through its initial public offer in FY25. The NBFC reported a capital adequacy ratio of 51.70% and gearing of 0.97x as of September 30, 2025.

The company demonstrated healthy profitability metrics with profit after tax of ₹33.20 crore in FY25, translating to return on managed assets of 5.70% and return on net worth of 11.10%. This represented an improvement from the previous year's figures of ₹18.50 crore PAT, 4.30% RoTA, and 8.80% RONW in FY24.

Rating Constraints and Challenges

Despite the positive rating assignment, CARE Ratings highlighted several constraints. The company's operations remain geographically concentrated with presence in only five states, with Rajasthan accounting for approximately 63% of overall assets under management as of September 30, 2025.

Geographic Distribution Percentage of Portfolio
Rajasthan 63%
Maharashtra 16%
Gujarat 14%
Madhya Pradesh 7%

The NBFC has grown at a modest pace with compound annual growth rate of 19% over the last four financial years, reaching AUM of ₹767 crore as of September 30, 2025. The rating also considers the company's limited resource profile with high reliance on financial institutions and NBFCs at 50% of total borrowings, along with higher cost of borrowing compared to peers.

Financial Performance and Outlook

Akme Fintrade's asset quality metrics showed improvement with gross non-performing assets declining to 2.77% as of March 31, 2025, from 3.63% in the previous year. The company maintains adequate provisions of 51% on its GNPA as of September 30, 2025.

Financial Metrics March 31, 2024 March 31, 2025 H1FY26
Total Income (₹ crore) 72.20 101.90 66.80
PAT (₹ crore) 18.50 33.20 19.70
AUM (₹ crore) 425.70 618.60 767.00
GNPA (%) 3.63% 2.77% 2.96%
CAR (%) 49.86% 59.27% 51.66%

The stable outlook reflects CARE Ratings' expectation that Akme Fintrade will continue maintaining comfortable gearing and liquidity positions while reporting healthy profitability metrics and keeping credit costs under control. The rating agency will monitor the performance of the company's expanding vehicle finance segment, which constituted 75% of total disbursements in the last 1.5 financial years.

Source:

Historical Stock Returns for Akme Fintrade

1 Day5 Days1 Month6 Months1 Year5 Years
+8.29%+18.31%+4.44%-15.15%-15.15%-95.59%

More News on Akme Fintrade (India)

1 Year Returns:-15.15%